The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...

Biotech is growing in North Carolina, and now one Triad college is stepping up to help train the workforce. Guilford Technical Community College is launching a ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

Wexner, who is chairman of the board and for whom the medical center is named, said that "probably the largest AI investment in the world will happen in Columbus" and predicted that "100 more" medical ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

Longevity Health Holdings has secured a temporary reprieve from Nasdaq delisting, but the clock is ticking as the ...

The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

Despite these positive clinical developments, Amgen and Viking Therapeutics have performed poorly on the stock market in the past 12 months, though progress in this area might eventually help them ...

A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some ...

Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...